Gene expression profiling of maternal plasma, urine, and blood reveals molecular signatures of placenta accreta and low-lying placenta
This triple-biofluid transcriptomic analysis reveals both shared and distinct molecular landscapes of PA and LLP, supporting a disease-spectrum model of abnormal placentation and systemic immune–metabolic reprogramming.